Last reviewed · How we verify

NCT04953026

SLAP Injury of the Shoulder Joint: Application Value of Deep Learning in Diagnosis

Status unknown Last updated 7 July 2021
What this trial tests

trial testing Diagnositic test in Superior Labrum From Anterior to Posterior Injuries in 800 participants. Status unknown.

Timeline
1 October 2021
Primary endpoint
1 June 2022
1 July 2022

Quick facts

Lead sponsorPeking University Third Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment800
Start date1 October 2021
Primary completion1 June 2022
Estimated completion1 July 2022
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Peking University Third Hospital

Who can join

Eligibility, any sex, with Superior Labrum From Anterior to Posterior Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study intends to study the shoulder SLAP injury through deep learning technology and establish a deep learning model through the combination of axial and oblique coronal images to establish a deep learning method that can accurately identify and grade shoulder SLAP injury.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Diagnositic test

Trials testing the same drug.

Other Peking University Third Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04953026.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing